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Abstract
This study aimed to determine the relative importance of
different functional and morphological pancreatic changes
induced by the chronic administration of a sucrose-rich
diet (SRD) to maintain normal glucose homeostasis. Male
Wistar rats were fed either sucrose (SRD) or starch (CD)
for 6 and 12 months. At both periods, serum glucose and
triacylglycerol levels were significantly higher (P<0·05;
paired and unpaired Student’s t-test) in SRD rats. Serum
insulin levels were significantly lower in SRD only at
12 months. At 6 months, the insulin secretion dose–
response curve in SRD rats showed a shift to the left that
was no longer observed at 12 months, when SRD islets
decreased their response to 16 mM glucose. At 6 months,
SRD rats showed a significant increase in â-cell volume
density (Vvi) and islet cell replication rate, together with a
decrease in â-cell apoptotic rate. Changes were not
detected in the percentage of PDX-1- and islet neogenesis
associated protein (INGAP)-positive cells. Conversely, at
12 months, there was a significant decrease in â-cell Vvi
and in the percentage of PDX-1-positive cells; the islet
cell replication rate was not modified, and the number
of apoptotic â-cells increased significantly. No signs of
increased neogenesis or INGAP-positive cells were
recorded at any period in SRD rats. Our results show that
SRD rats are unable to develop functional and morpho-
logical pancreatic reactive changes sufficient to maintain
normal glucose and triacylglycerol levels for a long period.
Such failure could be ascribed to their inability to increase
the rate of neogenesis and of INGAP production.
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Introduction
The chronic administration of a sucrose-rich diet (SRD)
to normal rats induces an insulin-resistant state character-
ized by moderate fasting hyperglycemia, increased trigly-
ceride and free fatty acid (FFA) levels, normoinsulinemia
and a modest increase in body weight (Cohen et al. 1977,
Lombardo et al. 1996, Chicco et al. 2003). Islets isolated
from these rats have a normal insulin content (Lombardo
et al. 1996, Del Zotto et al. 2002), but their secretion
pattern is characterized by the absence of the first peak and
the enhancement of the second phase of insulin release
in response to glucose (Chicco et al. 2003, Pighin et al.
2003). Islets from rats fed SRD for 9 months also had an
increased content of triglyceride and reduced pyruvate
dehydrogenase complex activity (PDHc) (Pighin et al.
2003). All these characteristics resemble those found in
people with type 2 diabetes (Polonsky et al. 1996, Clark
et al. 2001, Weir et al. 2001, Deng et al. 2004). After
6 months of SRD administration, the pancreas of these rats
showed a significant increase in both number of islets
and â-cell area (Lombardo et al. 1996, Del Zotto et al.
2002).
The effect of SRD on glucose homeostasis and on
pancreatic function and morphology has also been studied
in hamsters (Del Zotto et al. 1999, 2000, Massa et al.
2001). In hamsters fed this diet for 12 months, serum
glucose and triacylglycerol levels remained within normal
range. Insulin secretion was enhanced in vivo and in vitro,
and â-cell mass increased due to an increment in repli-
cation rate and islet neogenesis, while there were no
changes in the rate of â-cell apoptosis. It is not clear as yet
why rats and hamsters present such an uneven response to
the increased insulin demand induced by sustained SRD
administration.
In adult mammals, the mass of pancreatic â-cells
undergoes dynamic changes to maintain serum glucose
levels within normal range (Montanya et al. 2000), even
under extremely different conditions such as pregnancy
and obesity (Parsons et al. 1992, Milburn et al. 1995).
The resultant â-cell mass depends on a subtle balance
between cell growth and differentiation, and cell death
321
Journal of Endocrinology (2004) 183, 321–330
0022–0795/04/0183–321 ? 2004 Society for Endocrinology Printed in Great Britain
DOI: 10.1677/joe.1.05792
Online version via http://www.endocrinology-journals.org
Downloaded from Bioscientifica.com at 10/03/2019 09:37:43PM
via free access
(Shafrir et al. 1999, Bonner-Weir 2000). These processes
are controlled by several transcription and humoral factors
(Bonner-Weir & Smith 1994, Edlund 1998, Gradwohl
et al. 2000, Jensen et al. 2000, Perfetti et al. 2000,
McKinnon & Docherty 2001), probably including islet
neogenesis-associated protein (INGAP) (Rosenberg et al.
1983, Flores et. al 2003, Gagliardino et al. 2003). Disrup-
tion of this balance may lead to an impairment of glucose
homeostasis, such as the glucose intolerance developed
with ageing, with a reduction in â-cell replication rate
(Bonner-Weir 2000, Montanya et al. 2000). So far, it has
not been established whether all the processes involved in
this balance have either a similar or different importance in
gaining a functional â-cell mass sufficient to maintain
glucose homeostasis within the normal range.
In an attempt to answer this question, which is critical
to understand the pathogenesis of type 2 diabetes and to
develop appropriate strategies for the prevention and
treatment of the disease, we have currently studied insulin
secretion, volume density (Vvi), several indicators of islet
neogenesis, and replication and apoptotic rate of â-cells, as
well as the percentage of PDX-1- and INGAP-positive
cells in normal Wistar rats fed SRD for 6 (SRD6) and 12
(SRD12) months. These results were then compared with
those obtained previously in normal hamsters submitted to
a similar dietary manipulation.
Our results show that SRD6 rats presented increased
insulin secretion in vitro and â-cell Vvi, and this was
ascribable to both an increase in â-cell replication rate and
a decrease in apoptosis. However, all these functional and
morphological changes were not observed in SRD12. The
absence of increase in neogenesis rate and INGAP
response might explain the limited capacity of the rat
pancreas to cope with a sustained increased demand of
insulin. The increased levels of glucose and triacylglycerol
observed in SRD rats could also play a role in the
mechanism (glucolipotoxicity) limiting the long-term
reactive pancreas response.
Materials and Methods
Animals and diets
Normal male Wistar rats obtained from the National
Institute of Pharmacology, Buenos Aires, Argentina (180–
200 g body weight) were used. They were maintained in
a temperature-controlled room at 23 )C, with a fixed 12-h
light:12-h darkness cycle, and initially fed standard rat
laboratory chow (Ralston Purina, St Louis, MO, USA) to
standardise the nutritional status. After 1 week, the rats
were randomly divided into two groups: the experimental
group received a semisynthetic SRD (63% w/w), while
the control rats (CD) received the same semisynthetic diet
but with starch instead of sucrose in the same proportion
(63% w/w). Details of this procedure have been previously
reported (Chicco et al. 1994). Both diets provided
approximately 15·28 kJ/g chow. The animals had free
access to food and water and were maintained on their
respective diets for 6 and 12 months.
The weight of each animal was recorded twice per
week, while the individual caloric intake and weight gain
of at least 10 animals in each group were assessed twice per
week during the experimental period. On the day of the
experiment, food was removed at 0900 h, and experiments
were performed between 0900 and 1200 h. The experi-
mental protocol was approved by the Human and Animal
Research Committee of the School of Biochemistry,
Universidad Nacional del Litoral, Santa Fe, Argentina.
Blood parameters
Rats were anaesthetised with an intraperitoneal injection
of pentobarbital (60 mg/kg body weight), and blood
samples were drawn from the jugular vein and centrifuged
at 4 )C. The serum samples obtained were assayed either
immediately or within the next 3 days after having been
stored at "20 )C. Serum glucose (Bergmeyer 1974) and
triacylglycerol (Laurell 1966) levels were determined by
spectrophotometric methods. Insulin levels were deter-
mined by radioimmunoassay (RIA) (Herbert et al. 1965),
using an antibody against rat insulin, a rat-insulin standard
(Linco Research, St Charles, MI, USA) and highly puri-
fied porcine insulin labelled with 125I (Linde et al. 1980).
Insulin secretion in vitro
Groups of five islets isolated from pancreases of each
experimental group by collagenase digestion (Lacy &
Kostianovsky 1967) were incubated for 60 min at 37 )C in
0·6 ml of Krebs–Ringer bicarbonate (KRB) buffer,
pH 7·4, previously gassed with a mixture of CO2/O2
(5%/95%) and containing 0·1% (w/v) bovine serum
albumin and different glucose concentrations (0, 2, 4, 6, 8
and 16 mmol/l). At the end of the incubation period,
insulin was measured in the medium by RIA (Herbert
et al. 1965).
Immunohistochemical studies After removal of the
whole pancreas, the fat tissue was carefully dissected away.
Samples of the tail of the pancreas were then fixed in
Bouin’s fluid and embedded in paraffin wax; serial sections
(5 µm) were obtained from different levels of the blocks.
Haematoxylin–eosin staining was used to assess the
general structure of the pancreas. Each section from a
given series was mounted on separate slides to stain
adjacent sections for immunocytochemical identification
of insulin-secreting cells (â-cells) and glucagon-,
somatostatin- and pancreatic polypeptide-secreting cells
(non-â cells). For this purpose, specimens were incubated
with appropriate dilutions of our own guinea pig anti-
insulin serum (1:20 000) and a mixture of the other
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three rabbit antisera: antiglucagon (1:400), antipancreatic
polypeptide (1:10 000) (both kindly provided by Novo
Nordisk, Copenhagen, Denmark), and antisomatostatin
(1:6000) (a gift from Dr S. Efendic, Department of Endo-
crinology, Karolinska Institute, Copenhagen, Denmark).
The reaction was completed by the streptavidin–biotin
complex method, with either peroxidase or alkaline phos-
phatase, together with carbazole and fast blue respectively
as chromogens. Controls for serological specificity were
made by preincubating a given antiserum with an excess of
the corresponding hormone for 24 h at 4 )C.
Islet cell replication rate: double-immunolabelling studies
Islet cell replication rate was estimated by detecting
proliferating cell nuclear antigen (PCNA; 1:4000, Sigma)
by a modified avidin–biotin peroxidase method (Hsu et al.
1981). We quantified and expressed the replication rate as
the percentage of PCNA-labelled cells among the total
islet cells.
We performed double staining of the following pairs: a)
â cells (insulin antibody) and PCNA (PCNA antibody),
and b) non-â cells (glucagon, somatostatin and pancreatic
polypeptide pool) and PCNA. We then used the
streptavidin–biotin complex method, with peroxidase and
alkaline phosphatase, together with carbazole and fast blue
respectively as chromogens. Incubations with primary
antibodies were overnight, whereas those with the
secondary biotinylated antibodies were for 30 min.
Indicators of islet neogenesis
Cytokeratin immunostaining To reveal the presence
of cytokeratin (CK)-positive cells, we used a specific
monoclonal antibody for CK 19 (anti-CK clone 4·62;
1:40) (Sigma) and a panspecific cocktail of antibodies
against human CK clone AE1-AE3 (DAKO), and the
streptavidin-biotin complex method, with peroxidase and
carbazole as chromogens. Before performing the staining,
we treated deparaffinised sections with 250 ml antigen-
retrieval solution (Vector Laboratories, Burlingame,
CA, USA) for 10 min in a 500 W microwave oven
(Madsen et al. 1997). The number of CK-positive cells
was expressed as the percentage of the total islet cells
counted. We also estimated the relationship between the
islets and duct cells, measuring the percentage of the total
number of islets in close contact with the ducts (Bertelli
et al. 2001).
Detection of PDX-1- and INGAP-positive cells
Sequential double staining for PDX-1 and INGAP detec-
tion in pancreatic cells was as follows. We first stained
PDX-1 cells with the PDX-1 antibody (1:1200; kindly
provided by Dr C. Wright, Department of Cell Biology,
Vanderbilt University, Nashville, TN, USA), and revealed
them as described above, using carbazole as chromogen;
the same section was then immunostained with the
INGAP antibody (1:250), except that alkaline phosphatase
and fast blue (Sigma) were used as chromogens. Then, the
percentage of cells expressing separately or co-expressing
these two factors was quantified within each subsector of
the pancreas, that is, islet, extrainsular, and duct cells (no
fewer than 1000 each). Furthermore, glucagon (fluor-
escein) and somatostatin (Texas red) were used to
reveal co-expression of these hormones with PDX-1 and
INGAP.
â-cell apoptotic rate: double-labelling studies To
identify apoptotic cells, we used the propidium iodide
technique (Scaglia et al.1997). Deparaffinised and hydrated
sections were washed in PBS before incubation for 30 min
in a dark, humidified chamber with a solution of propid-
ium iodide (4 µg/ml; Sigma) and ribonuclease A (100 µg/
ml; Sigma). Then, the sections pretreated with non-
immune sera from rabbit diluted in Tris-buffered saline
(pH 7·4) were incubated for 1 h with the glucagon
antibody. After washing with PBS, fluorescence labelling
of primary antibody was accomplished through a second
incubation at room temperature for 45 min in the dark
with the IgG-specific, fluorescein-conjugated, affinity-
purified goat antibody (against heavy and light IgG chains;
Jackson Immuno Research Laboratories, Baltimore, MD,
USA). After another washing with PBS, the sections were
mounted in Tris–glycerol (pH 8·4) for analysis by fluor-
escence microscopy. Using this double labelling, we
obtained â-cells surrounded by an immunofluorescent
ring of á cells. A Zeiss Axiolab epifluorescence microscope
equipped with an HBO50 mercury lamp, together with
two different filters, was used to visualise autofluorescent
labelling. For the quantitative evaluation of immunofluor-
escence, positively labelled apoptotic endocrine cells were
counted under a #40 objective lens in sections obtained
from different levels of the blocks. The number of
apoptotic cells was expressed as the percentage of the total
number of islet cells counted.
Morphometrical analysis The morphometrical analysis
was performed by videomicroscopy with a Jenamed 2
Carl Zeiss light microscope and an RGB CCD Sony
camera in combination with OPTIMAS software
(Bioscan, Edmons, WA, USA). We were then able to
obtain the area occupied by the endocrine pancreas, the
exocrine pancreas, the total pancreas, â and non-â cells,
and several ratios and relationships, as described in the
Results section. We also estimated the number of islets
per unit area (mm2) and â-cell Vvi. In addition, the
ratio of islet cell area to number of islet cells (â and
non-â) was calculated to obtain cell size. Every islet or
small group of endocrine cells was recorded in each
section, thus obtaining the number and areas of both â
and non-â cells.
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Statistical analysis
Data are presented as means&S.E.M. The statistical analysis
was performed with paired and unpaired Student’s t-test.
A P value of <0·05 was considered significant.
Results
At the time of death, body weight in SRD6 was signifi-
cantly higher than in the corresponding CD group
(P<0·05), whereas such difference was not significant in
SRD12 (Table 1).
Both serum glucose and triacylglycerol levels were also
significantly higher in both SRD6 and SRD12 (P<0·05),
triacylgycerol levels being even higher in SRD12
(Table 1). Serum insulin levels were comparable in SRD6
and CD6, whereas they were significantly lower in
SRD12 than in either SRD6 or CD12 rats (P<0·05;
Table 1).
Insulin secretion elicited in vitro by different glucose
concentrations is shown in Fig. 1. The dose–response
curve obtained with islets from SRD6 shows a shift to the
left (Fig. 1a), thus suggesting a decreased â-cell glucose
threshold for the glucose stimulus. Such an effect was no
longer observed in islets isolated from SRD12 animals
(Fig. 1b), excepting glucose at 8 mM; these islets also
released less insulin in response to 16 mM glucose.
Sections from CD6 and SRD6 stained with
haematoxylin–eosin revealed the general, normal histo-
logical pancreatic appearance. Furthermore, in both
groups of animals, immunohistochemistry showed the
usual topographic distribution of cells within the islets,
with â-cells occupying the central zone and non-â cells
located at the islet periphery. Conversely, pancreases from
SRD12 rats showed striking changes in morphology, with
islets disrupted by fibrous tissue.
SRD6 animals showed a significant increment in the
number of pancreatic islets per unit area and in â-cell Vvi
(P<0·02), together with a 6·8-fold increase in â-cell
replication rate (Table 2 and Fig. 2a and b); although to a
lesser extent, non-â-cell Vvi was also larger in SRD than
in CD animals (0·19&0·03 vs 0·09&0·01; P<0·02).
Comparable values, however, were recorded in endocrine
cell size (in µm2, CD vs SRD): â-cells, 121·48&9·73 vs
118·35&6·46; non-â cells, 97·55&6·24 vs 95·59&7·05).
The number of apoptotic cells in the endocrine pancreas
of SRD6 animals (Fig. 2k; Table 2) was three times lower
than that counted in CD rats (Fig. 2j) (P<0·02).
As an index of islet neogenesis, we measured the islet
diameter, the percentage of CK-positive cells (Fig. 2g
and h; Table 3), the number of islets in close contact
with the ducts, the number of insulin-reacting ductal
Table 1 Clinical and serological changes induced by SRD feeding
Body weight
(g)
Glycaemia
(mmol/l)
Triacylglycerol
(mmol/l)
Insulin
(ìU/ml)
Group
CD6 470·0&13·0- 6·62&0·17- 0·47&0·04- 55·0&4·9
SRD6 556·0&8·0; 8·11&0·14 1·57&0·18; 50·8&5·8;
CD12 491·0&9·0 6·50&0·20- 0·50&0·02- 58·8&0·2-
SRD12 520·0&11·0 8·30&0·20 2·10&0·02 23·0&2·0
Values represent the mean of four rats in each group&S.E.M.
-CD vs SRD (at either 6 or 12 months); ;SRD6 vs SRD12; -;P<0·05.
CD6 vs CD12, NS.
Figure 1 Insulin secretion: (a) CD6 vs SDR6 rats; (b) CD12 vs
SDR12 rats. Each point in the line represents the mean of 15
cases from three different experiments&S.E.M. *P<0·05.
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epithelium cells, and the percentage of islet PDX-1-
positive cells (Fig. 2d and e; Table 3). None of these
indicators showed significant changes in pancreases from
SRD6 rats. The percentage of INGAP-positive cells in the
islets was comparable in both groups of animals at this
period (Fig. 2d and e; Table 3). We did not record either
â-cells or PDX-1- and INGAP-positive cells at duct level
at either 6 or 12 months. PDX-1-positive cells were also
undetectable among acinar cells.
Data recorded in SRD12 animals were markedly differ-
ent: there was a significant decrease in the number of islets
(P<0·02) and in â-cell Vvi (P<0·02), attaining values
close to those recorded in CD6 rats (Table 2). We also
observed a non-significant increase in PCNA index rate
(Fig. 2c and Table 2).
Comparable values were recorded in both groups of
animals in non-â-cell Vvi (%) – CD vs SRD: 0·10&0·01
vs 0·20&0·03; P<0·02. Similarly, islet cell-size values
were also comparable in CD and SRD rats: â-cells,
129·48&10·00 vs 121·35&7·00; non-â cells, 98·00&6·20
vs 96·00&7·10 µm2.
In contrast to what we found at 6 months, a significant
increase in â-cell apoptotic rate was obtained in SRD12
rats (P<0·02). This increase was more marked when
values were compared with those recorded in SRD6 rats
(Fig. 2l and Table 2).
In SRD12, at 6 months, the islet neogenesis indicators
did not show significant changes, except for a marked
reduction in the percentage of islet PDX-1-positive cells
recorded in SRD rats (P<0·005) (Fig. 2f and Table 3).
The number of INGAP-positive cells decreased signifi-
cantly in SRD12 (P<0·02) (Fig. 2f and Table 3). This
decrease was striking, considering that the number of
INGAP-positive cells was significantly higher in CD12
than CD6. PDX-1- and INGAP-positive cells were not
present at acinar and ductal level (data not shown).
Discussion
Our current results show that the chronic administration of
SRD to normal rats induces uneven sequential changes
both in insulin secretion and in the morphology of the
endocrine pancreas.
It has been previously shown that the increased demand
of insulin induced by different experimental procedures
triggers a shift to the left in the in vitro dose–response curve
profile of glucose-induced insulin release, in both rats and
hamsters (Leahy 1996, Massa et al. 1997, 2001, Del Zotto
et al. 1999). This effect could be partly ascribed to a
change in the hexokinase:glucokinase ratio of islet cells
(Leahy 1996, Massa et al. 2001), resulting in increased
islet glucose metabolism (Massa et al. 2001). These results
agree with the significantly higher second phase of insulin
released by perifused islets in response to glucose reported
in this animal model, as reported by Pighin et al. (2003).
As described in that report, while insulin secretion in vitro
was higher in SRD6 rats than in CD rats, their serum
insulin levels were not. This apparent discrepancy be-
tween in vitro and in vivo results could be ascribed to the
inhibitory effect of high levels of circulating fatty acids
reported by our group (Pighin et al. 2003) and other
authors as well (Zhou & Grill 1995, Chen & Reaven
1999). Consequently, the circulating levels of insulin in
SRD6 rats were insufficient to cope with the increased
peripheral demand of insulin, since these animals had
significantly higher serum glucose and triacylglycerol
levels than CD rats. These reactive changes in insulin
secretion were no longer evident and even reversed at
12 months.
The fact that blood glucose levels are comparable in
SRD6 and SRD12, and that insulin levels are lower in
the former, would suggest that peripheral tissues have
modified the sensitivity of SRD12 to insulin.
Our results indicate that normal rat islets can sustain the
secretory overload elicited by the dietary-induced insulin-
resistant state only for a limited period of time. Such
limitation could be genetically determined, since normal
hamsters submitted to a similar chronic SRD treatment
can sustain this response for a significantly longer
period (Del Zotto et al. 1999, 2000). On account of the
enhancing effect of endogenous insulin upon insulin and
glucokinase transcription (Leibiger et al. 2002), glucose
metabolism in the islets and insulin secretion of normal
Table 2 Morphometrical analysis of pancreases from 6- and 12-month SRD or CD rats
Number of islets
(mm2)
â-cell Vvi
(%)
PCNA index rate
(%)
Apoptotic index rate
(%)
Group
CD6 2·0&0·2-♣ 0·4&0·2- 0·04&0·03- 4·3&1·1-
SRD6 3·3&0·1; 1·0&0·1; 0·30&0·10 1·4&0·5;
CD12 3·0&0·1- 0·8&0·1- 0·10&0·08 4·9&0·5-
SRD12 1·8&0·1 0·5&0·07 0·40&0·20 13·5&0·5
Values represent the mean of four rat pancreases and three section levels&S.E.M.
-CD vs SRD (either at 6 or 12 months); ♣CD6 vs CD12; ;SRD6 vs SRD12. In all cases, P<0·02.
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hamsters (Borelli et al. 2003), the decreased release of
insulin observed in SRD12 rats could establish a vicious
negative circle contributing to the lower capacity of rats to
cope with the increased demand of insulin.
The limited time-capacity of the rat pancreas to cope
with a prolonged period of sustained insulin resistance is
an important issue when we consider the implementation
of prevention strategies. We and other authors have
previously shown that replacement of sucrose by starch
(Chicco et al.1999), administration of fish oil (Storlien et al.
1987, Lombardo et al. 1996, Soria et al. 2002) and
troglitazone (Chicco et al. 2000) in the diet restored the
altered pattern of serum lipids, insulin sensitivity, and
glucose-induced insulin secretion in rats chronically fed
a SRD. These results indicate that all these impaired
functions are reversible and can be recovered when the
animals receive the treatment in an appropriately timely
manner. It remains to be demonstrated whether – and to
Figure 2 Pancreatic islets stained with different antibodies to show Vvi â and replication rate, neogenesis and apoptosis. Double
immunolabelling: nuclei are stained with proliferating cell nuclear antibody (PCNA) (arrows), while the cytoplasm shows insulin
immunostaining (a, CD6; b, SRD6; c, SRD12; ×100); â-cell nuclei are stained with PDX-1 (carbazole) and the periphery with INGAP (fast
blue) (d, CD6; e, SRD6; f, SRD12; ×200); CK19-immunolabelled pancreatic islet; positive-reacting non-â-cells are seen in the periphery;
counterstaining with haematoxylin (g, CD6; h, CD12; I, SRD12; ×100). Pancreatic cells with glucagon-positive cells in the periphery
(immunofluorescence); apoptotic nuclei (propidium iodide) corresponding to â cells are seen in the central zone of the islets (arrows)
(j, CD6; k, SRD6; l, SRD12; ×100).
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what extent – the same happens with the morphological
SRD-induced islet cell alterations.
The pancreatic â-cell mass was also modified by the
challenge of the increased demand of insulin induced by
SRD administration (Lombardo et al. 1996, Del Zotto
et al. 2002). We have currently reproduced the increase in
â-cell Vvi observed in SRD6 rats reported by Lombardo
et al. (1996). As occurred previously, this effect was due to
an increase in the replication rate of these cells together
with a marked decrease in their apoptotic rate (Del Zotto
et al. 2002). In SRD12, however, the rate of PCNA was
no longer increased and the apoptotic rate was significantly
increased rather than decreased.
Apoptosis is a morphologically identifiable form of cell
death triggered by a variety of metabolic stimuli, and it
plays an important role in remodelling â-cell mass as the
counterpart of proliferation (Wyllie et al. 1980, Steller
1995, Scaglia et al. 1997, Shafrir et al. 1999). Thus, it has
been shown that â-cell expansion can be offset by
concomitant apoptosis (Pick et al. 1998). Hoorens et al.
(1996) postulated that rat â-cell apoptosis is blocked by
proteins whose synthesis is stimulated by glucose in a
dose-dependent manner, while Donath et al. (1999) and
Federici et al. (2001) showed that glucose increases this
rate by triggering an ‘on and off’ expression of specific
genes. The decreased rate of â-cell apoptosis recorded in
SRD6 and its increase in SRD12 could be ascribed to
these two opposite mechanisms triggered by glucose.
These results suggest that changes in apoptosis could
explain the increased/decreased â-cell Vvi measured at
the two periods, but these changes could not provide
â-cells functionally sufficient to maintain normal levels of
serum glucose and triacylglycerol.
We assessed the possible contribution of islet neogenesis
to increasing â-cell Vvi by the use of several indicators
such as the presence of cytokeratins (CKs) (Bowens et al.
1994, Wang et al. 1995) and the increase in replication
rate, number of insulin-labelled cells at the ductal com-
partment (Bowens & Klöppel 1996), proportion of small
islets and of islets closely associated with the ductal
epithelium (Bertelli et al. 2001), and percentage of PDX-
1-positive cells (Sharma et al. 1999, Perfetti et al. 2000,
Stoffers et al. 2000). None of these indicators showed
significant changes in SRD animals, thus suggesting that,
in our rat experimental model, islet neogenesis was not
involved in the mechanism responsible for the increment
of â-cell Vvi.
Altogether, the reactive morphological changes, as well
as insulin secretion, were time-limited and failed to
overcome the sustained increased demand of insulin
elicited by the chronic administration of SRD to normal
rats.
We could observe substantial differences when we
compared these data with those previously obtained in
normal hamsters fed a SRD (Del Zotto et al. 1999, 2000,
Massa et al. 2001). In these animals, both the shift in the
dose–response curve (glucose stimulus) and the increase in
â-cell Vvi and mass were sustained for up to 12 months.
Another conspicuous difference was that hamsters showed
an initial increase in islet neogenesis and in the number of
INGAP-positive cells. In contrast to those observed in
rats, the reactive changes detected in pancreas function
and morphology in hamsters were sufficient to maintain
fasting serum glucose and triacylglycerol levels within the
normal range. We also found that the ratio â-cell mass/
body weight was three times larger in hamsters than in rats
(Del Zotto et al. 2000). We therefore assumed that in order
to maintain normal serum glucose and triacylglycerol
levels for a long period after SRD administration, islet
neogenesis must be present to ensure a sufficiently func-
tional â-cell mass. Accordingly, SRD rats cannot maintain
those parameters within a normal range due to their
inability to reassume islet neogenesis in adult life.
It has been claimed that INGAP stimulates islet neo-
genesis (Rosenberg et al. 1983, Rafaeloff et al. 1997). In
addition, we have previously shown an increase in the
number of INGAP-positive cells accompanying the
increased neogenesis rate induced by the chronic admini-
stration of SRD to normal hamsters (Del Zotto et al.
2000). Furthermore, in newborn hamsters fed a SRD
during pregnancy, we identified the presence of islet and
ductal cells with high replication rate co-expressing
PDX-1 and INGAP (Gagliardino et al. 2003). In the
rat, therefore, the absence of islet neogenesis signs,
accompanied by either no changes (SRD6) or a decrease
(SRD12) in the percentage of INGAP-positive cells,
Table 3 Changes induced by SRD feeding upon indicators of islet neogenesis
Islet diameter
(ìm)
Cytokeratin islet index rate
(%)
Islet in contact with ducts
(%)
PDX-1+ islet cells
(%)
INGAP+ islet cells
(%)
Group
CD6 160&5 11·6&3·1 40&5 58·3&1·3♣ 0·12&0·01♣
SRD6 173&12 13·9&2·5 43&6 69·3&12·0; 0·14&0·02
CD12 161&8 15·0&4·0 42&4 45·7&2·9- 0·20&0·03-
SRD12 169&4 12·8&5·0 41&5 32·4&3·2 0·10&0·01
Values represent the mean of four rat pancreases and three section levels&S.E.M.
-CD vs SRD (either at 6 or 12 months); ♣CD6 vs CD12; ;SRD6 vs SRD12. In all cases, P<0·02.
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clearly contrasts with observations in the hamster, indicat-
ing a cause-effect relation rather than a simple coinci-
dence. Although fully within the field of speculation, we
might assume that the significant increase of INGAP-
positive cells depicted in CD12 as compared with CD6
rats represents an effort of the rat pancreas to compensate
for the low – or absent – neogenetic response to the
INGAP stimulus (INGAP resistance?).
The moderate hyperglycaemia present in our rats and
the altered glucose oxidation (decreased activity of the
PDHc complex) recently reported in the same experimen-
tal model (Pighin et al. 2003) could represent an additional
factor limiting the functional and morphological pancreas
reaction. In fact, hyperglycaemia can impair the secretion
of insulin (Leahy et al. 1986, Rossetti et al. 1987, Portha
et al. 1988, Leahy 1996, Deng et al. 2004), the rate of
â-cell replication and the degree of islet neogenesis
(Maedler et al. 2001). Furthermore, it can also increase the
rate of â-cell apoptosis (Donath et al. 1999, Federici et al.
2001, Maedler et al. 2001). The deleterious effect of
glucose involves an impaired expression of genes related to
glucose utilisation, â-cell replication and islet neogenesis
(Weir et al. 2001, Laybutt et al. 2002). Hyperglycaemia,
together with the increased triacylglycerol serum levels
and the content of islet triglycerides (Pighin et al. 2003) –
gluco-lipotoxicity – could affect all these processes by
increasing the rate of oxidative stress (Sakuraba et al. 2002,
Robertson et al. 2004).
In brief, our current results and those previously
reported by our group (Del Zotto et al. 1999, 2000,
Gagliardino et al. 2003) show that the response of two
animal models to a similar â-cell function overload is
different, and that this response would be genetically
determined. Thus, the efficacy of the mechanisms
that attempt to control an increased demand of insulin
induced by similar experimental procedures can vary, and
these mechanisms may cause either a compensatory
hyperinsulinaemic–normoglycaemic state or a diabetic
state. In this context, the development of neogenesis
would play a key role in obtaining a successful sustained
adaptation to the increased demand of insulin. The con-
comitant absence of increase in the number of INGAP-
positive cells and lack of a neogenetic reaction would
support the idea of a stimulatory effect of this peptide upon
neogenesis (Rosenberg et al. 1983, Rafaeloff et al. 1997,
Del Zotto et al. 2000, Gagliardino et al. 2003). When
neogenesis is absent, at least in our model, the other
pancreatic reactive mechanisms cannot ensure such adap-
tation. At present, therefore, either removing or decreasing
the insulin demand would be the most reasonable strategy
to prevent diabetes manifestations in cases where neo-
genesis is not present. The fact that administration of fish
oil to SRD rats improves pancreatic damage and metabolic
homeostasis (Pighin et al. 2003) lends further support to
this assumption. Further studies using models similar to the
one currently used may help to determine the molecular
mechanisms conditioning either the success or the failure
of the pancreatic compensatory response to a functional
overload.
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